Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.
Clinical trial NCT00562055 · WITHDRAWN
Trial details
- NCT number
- NCT00562055
- Sponsor
- Pfizer
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.